Celularity Inc. Marketable Securities, Unrealized Gain (Loss)
Celularity Inc. (CELU) reported Marketable Securities, Unrealized Gain (Loss) of -$471.50 thousand for the 3-month period ending 2020-06-30, per its 10-Q filed 2021-08-19.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2021-08-19
- Celularity Inc. marketable securities, unrealized gain (loss) for the quarter ending 2020-06-30 was -$471.50K.
- Celularity Inc. marketable securities, unrealized gain (loss) for the quarter ending 2020-03-31 was $389.95K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month |
|---|---|---|
| 2020-06-30 | -$471.50K 10-Q · filed 2021-08-19 | -$41.61K 10-Q · filed 2021-08-19 |
| 2020-03-31 | $389.95K 10-Q · filed 2021-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |